CureLeads, a leading MENA BioPharma company and ANSEA a global healthcare consulting firm, have formed a strategic partnership. CureLeads, will enable ANSEA’s healthcare consulting services across the MENA region, leveraging its strong regional presence and stakeholder relationships.
Mohamad Rammal, CureLeads, CEO, said, “Our partnership will bring innovative therapies and global best practices to drive patient access faster.”
”With CureLeads, deep understanding of MENA healthcare systems that are rapidly evolving into value-based assessment, ANSEA can expand its services in this fast-evolving market,” added Anand Jha, ANSEA Founder and Managing Director.